NeuroScientific hails 80% clinical response in Crohn’s stem cell program
--------------------------------------------------------------------
Source: The Age
Published: 2026-05-26 12:02 UTC+10:00
Section: Business / Companies
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Business & Economy
--------------------------------------------------------------------
Snippet:
NeuroScientific Biopharmaceuticals has delivered another promising set of patient outcomes from its StemSmart stem cell therapy, reporting that four of the five patients treated for fistulising Crohn’s disease under its Special Access Program demonstrated a clinical response.
--------------------------------------------------------------------